Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

4D Molecular Therapeutics (FDMT) Preferred Shares Issued (2020)

4D Molecular Therapeutics (FDMT) has disclosed Preferred Shares Issued for 1 consecutive years, with -$32000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Preferred Shares Issued changed N/A to -$32000.0 in Q3 2020 year-over-year; TTM through Dec 2021 was -$32000.0, a N/A change, with the full-year FY2020 number at $72.5 million, up 724780.0% from a year prior.
  • Preferred Shares Issued was -$32000.0 for Q3 2020 at 4D Molecular Therapeutics.
  • In the past five years, Preferred Shares Issued ranged from a high of -$32000.0 in Q3 2020 to a low of -$32000.0 in Q3 2020.